![[PDF]](/pb-assets/Icons/adobe-pdf-icon-1498649896243.png){kind=icon}
Abstract
Introduction:
New psychoactive substances (NPS) pose a public health threat. Many studies have tried to identify the reasons of NPS use; however, none of them have so far used any standardised measures. The aim of this study was (i) to develop and cross-culturally validate the New Psychoactive Substance Use Motives Measure (NPSMM) and (ii) to compare motives of NPS use across countries and user types.
Methods:
Three subgroups (socially marginalised users, nightlife attendees and members of online communities) of NPS users (N = 3023) were recruited from six EU member countries. Demographics, motives and types of NPS used were assessed. NPS use motives were measured by adapting the extended six-factor version of the Marijuana Motives Measure.
Results:
Exploratory and confirmatory factor analysis resulted in a similar five-factor solution across most of the countries: coping, enhancement, social, conformity and expansion motives. Marginalised users scored higher on coping and conformity motives, nightlife groups showed higher endorsement of social motive, whereas online community users showed higher scores on expansion motives. Various types of NPS were also associated with different motives.
Conclusion:
NPS use motives might be associated with both the groups of users and the specific types of NPS being consumed. Expansion (psychedelics) and enhancement (stimulants) motives seemed to be linked to the chosen NPS product type, while coping, social and conformity motives were rather associated with user groups. NPSMM was found to be a valid instrument to measure NPS motives.
References
|
Armeli, S, Dranoff, E, Tennen, H, et al. (2014) A longitudinal study of the effects of coping motives, negative affect and drinking level on drinking problems among college students. Anxiety Stress Coping 27: 527–541. Google Scholar | Crossref | Medline | ISI | |
|
Barnard, M, Russell, C, McKeganey, N, et al. (2017) The highs and lows of NPS/“legal high” use: qualitative views from a UK online survey. Drugs Educ Prevent Policy 24: 96–102. Google Scholar | Crossref | |
|
Barratt, MJ, Cakic, V, Lenton, S (2013) Patterns of synthetic cannabinoid use in Australia. Drug Alcohol Rev 32: 141–146. Google Scholar | Crossref | Medline | |
|
Bedi, G, Hyman, D, de Wit, H (2010) Is ecstasy an “empathogen”? Effects of MDMA on prosocial feelings and identification of emotional states in others. Biol Psychiatry 68: 1134–1140. Google Scholar | Crossref | Medline | ISI | |
|
Benschop, A, Bujalski, M, Dabrowska, K, et al. (2017) New Psychoactive Substances: Transnational Project on Different User Groups, User Characteristics, Extent and Patterns of Use, Market Dynamics, and Best Practices in Prevention. NPS-transnational Project (HOME/2014/JDRU/AG/DRUG/7077). Amsterdam, The Netherlands: University of Amsterdam. Available at: https://pure.uva.nl/ws/files/18260517/Final_report.pdf (accessed 21 December 2017). Google Scholar | |
|
Benschop, A, Liebregts, N, van der Pol, P, et al. (2015) Reliability and validity of the Marijuana Motives Measure among young adult frequent cannabis users and associations with cannabis dependence. Addict Behav 40: 91–95. Google Scholar | Crossref | Medline | |
|
Bonar, EE, Ashrafioun, L, Ilgen, MA (2014) Synthetic cannabinoid use among patients in residential substance use disorder treatment: prevalence, motives, and correlates. Drug Alcohol Depend 143: 268–271. Google Scholar | Crossref | Medline | |
|
Brown, T (2006) Confirmatory Factor Analysis for Applied Research. New York: Guilford Press. Google Scholar | |
|
Buckner, JD, Zvolensky, MJ, Farris, SG, et al. (2014) Social anxiety and coping motives for cannabis use: the impact of experiential avoidance. Psychol Addict Behav 28: 568–574. Google Scholar | Crossref | Medline | |
|
Caviness, CM, Tzilos, G, Anderson, BJ, et al. (2015) Synthetic cannabinoids: use and predictors in a community sample of young adults. Subst Abus 36: 368–373. Google Scholar | Crossref | Medline | ISI | |
|
Chabrol, H, Ducongé, E, Casas, C, et al. (2005) Relations between cannabis use and dependence, motives for cannabis use and anxious, depressive and borderline symptomatology. Addict Behav 30: 829–840. Google Scholar | Crossref | Medline | ISI | |
|
Cheung, GW, Rensvold, RB (2002) Evaluating goodness-of-fit indexes for testing measurement invariance. Struct Equ Model 9: 233–255. Google Scholar | Crossref | ISI | |
|
Cooper, ML (1994) Motivations for alcohol use among adolescents: development and validation of a four-factor model. Psychol Assess 6: 117–128. Google Scholar | Crossref | |
|
Corazza, O, Simonato, P, Corkery, J, et al. (2014) “Legal highs”: safe and legal “heavens”? A study on the diffusion, knowledge and risk awareness of novel psychoactive drugs among students in the UK. Riv Psichiatr 49: 89–94. Google Scholar | Medline | |
|
Corkery, JM, Orsolini, L, Papanti, D, et al. (2017) From concept(ion) to life after death/the grave: the ‘natural’ history and life cycle(s) of novel psychoactive substances (NPS). Hum Psychopharmacol Clin Exp 32: e2566. Google Scholar | Crossref | |
|
Cox, WM, Klinger, E (1988) A motivational model of alcohol use. J Abnorm Psychol 97: 168–180. Google Scholar | Crossref | Medline | ISI | |
|
Dimitrov, D (2010) Testing for factorial invariance in the context of construct validation. Meas Eval Couns Dev 43: 121–149. Google Scholar | SAGE Journals | ISI | |
|
Dolengevich-Segal, H, Rodríguez-Salgado, B, Gómez-Arnau, J, et al. (2016) Severe psychosis, drug dependence, and hepatitis C related to slamming mephedrone. Case Rep Psychiatry 8379562. doi:10.1155/2016/8379562. Google Scholar | Crossref | Medline | |
|
EMCDDA (2017a) High-risk Drug Use and New Psychoactive Substances. EMCDDA Rapid Communication. Luxembourg: Publications Office of the European Union. Available at: http://www.emcdda.europa.eu/system/files/publications/4540/TD0217575ENN.pdf_en (accessed 28 November 2017) Google Scholar | |
|
EMCDDA (2017b) Germany - Country Drug Report 2017. Luxembourg: Publications Office of the European Union. Available at: http://www.emcdda.europa.eu/system/files/publications/4528/TD0416906ENN.pdf (accessed 27 November 2019) Google Scholar | |
|
EMCDDA (2019) EU Drug Markets Report 2019. Publications Office of the European Union, Luxembourg. Available at: http://www.emcdda.europa.eu/system/files/publications/12078/20192630_TD0319332ENN_PDF.pdf (accessed 26 November 2019) Google Scholar | |
|
Finney, SJ, DiStefano, C (2006) Non-normal and categorical data in structural equation modeling. In: GR, Hancock, RO, Mueller (eds) Structural Equation Modeling: A Second Course. Greenwich, CT: Information Age, pp. 269–314. Google Scholar | |
|
Gallimore, AR (2015) Restructuring consciousness – the psychedelic state in light of integrated information theory. Front Hum Neurosci 9: 346. Google Scholar | Crossref | Medline | |
|
Gittins, R, Guirguis, A, Schifano, F, et al. (2018) Exploration of the use of new psychoactive substances by individuals in treatment for substance misuse in the UK. Brain Sci 8: 58. Google Scholar | Crossref | |
|
Hunt, G, Moloney, M, Evans, K (2009) Epidemiology meets cultural studies: studying and understanding youth cultures, clubs and drugs. Addict Res Theory 17: 601–621. Google Scholar | Crossref | Medline | ISI | |
|
Johansson, A, Lindstedt, D, Roman, M, et al. (2017) A non-fatal intoxication and seven deaths involving the dissociative drug 3-MeO-PCP. Forensic Sci Int 275: 76–82. Google Scholar | Crossref | Medline | |
|
Kapitány-Fövény, M, Mervó, B, Corazza, O, et al. (2015) Enhancing sexual desire and experience: an investigation of the sexual correlates of gamma-hydroxybutyrate (GHB) use. Hum Psychopharmacol 30: 276–284. Google Scholar | Crossref | Medline | |
|
Karila, L, Megarbane, B, Cottencin, O, et al. (2015) Synthetic cathinones: a new public health problem. Curr Neuropharmacol 13(1): 12–20. Google Scholar | Crossref | Medline | |
|
Kelly, BC, Wells, BE, Pawson, M, et al. (2013) Novel psychoactive drug use among younger adults involved in US nightlife scenes. Drug Alcohol Rev 32: 588–593. Google Scholar | Crossref | Medline | ISI | |
|
Kettner, H, Mason, NL, Kuypers, KPC (2019) Motives for classical and novel psychoactive substances use in psychedelic polydrug users. Contemp Drug Probl 46: 304–320. Google Scholar | SAGE Journals | |
|
Korf, DJ, Benschop, A, Werse, B, et al. (2019) How and Where to Find NPS Users: a Comparison of Methods in a Cross-National Survey Among Three Groups of Current Users of New Psychoactive Substances in Europe. Int J Ment Health Ad. Epub ahead of print 17 January 2019. doi:10.1007/s11469-019-0052-8 Google Scholar | Crossref | |
|
Lauritsen, KJ, Rosenberg, H (2016) Comparison of outcome expectancies for synthetic cannabinoids and botanical marijuana. Am J Drug Alcohol Abuse 42: 377–384. Google Scholar | Crossref | Medline | |
|
Mackinnon, SP, Couture, ME, Cooper, ML, et al.; DRINC Team (2017) Cross-cultural comparisons of drinking motives in 10 countries: data from the DRINC project. Drug Alcohol Rev 36: 721–730. Google Scholar | Crossref | Medline | |
|
MacLeod, K, Pickering, L, Gannon, M, et al. (2016) Understanding the Patterns of Use, Motives, and Harms of New Psychoactive Substances in Scotland. Edinburgh, UK: Scottish Government. Available at: http://www.gov.scot/Resource/0051/00510607.pdf (accessed: 28 November 2017). Google Scholar | |
|
Martinotti, G, Lupi, M, Carlucci, L, et al. (2015) Novel psychoactive substances: use and knowledge among adolescents and young adults in urban and rural areas. Hum Psychopharmacol 30: 295–301. Google Scholar | Crossref | Medline | ISI | |
|
Matthews, AJ, Bruno, R (2010) Mephedrone Use Among Regular Ecstasy Consumers in Australia. EDRS Drug Trends Bulletin, December. Sydney: National Drug and Alcohol Research Centre, University of New South Wales. Google Scholar | |
|
Midgley, LS, Murphy, S, Moore, G, et al. (2018) Multilevel population-based cross-sectional study examining school substance-misuse policy and the use of cannabis, mephedrone and novel psychoactive substances among students aged 11-16 years in schools in Wales. BMJ Open 8: e020737. Google Scholar | Crossref | Medline | |
|
Muthén, LK, Muthén, BO (2017) Mplus User’s Guide. 8th ed. Los Angeles, CA: Muthén & Muthén. Google Scholar | |
|
Nabben, T, Benschop, A, Korf, DJ (2014) Antenne 2013. Trends in Alcohol, tabak en drugs bij jonge Amsterdammers. Amsterdam: Rozenberg Publishers. Google Scholar | |
|
Newcombe, R (2009) The Use of Mephedrone (M-cat,Meow) in Middlesbrough. Manchester, UK: Lifeline Publications and Research Google Scholar | |
|
Orsolini, L, Papanti, D, Corkery, J, et al. (2017) An insight into the deep web; why it matters for addiction psychiatry? Hum Psychopharmacol 32: e2573. Google Scholar | Crossref | |
|
Orsolini, L, Papanti, GD, Francesconi, G, et al. (2015) Mind navigators of chemicals’ experimenters? A web-based description of e-psychonauts. Cyberpsychol Behav Soc Netw 18: 296–300. Google Scholar | Crossref | Medline | |
|
Orsolini, L, Chiappini, S, Corkery, JM, et al. (2019) The use of new psychoactive substances (NPS) in young people and their role in mental health care: a systematic review. Expert Rev Neurother 19: 1253–1264. Google Scholar | Crossref | |
|
Paksi, B, Magi, A, Felvinczi, K, et al. (2016) The Prevalence of New Psychoactive Substances in Hungary – Based on a General Population Survey Dealing with Addiction Related Problems (OLAAP 2015). IV. International Conference on Novel Psychoactive Substances (NPS). Budapest, 30–31 May 2016. Google Scholar | |
|
Palamar, JJ, Martins, SS, Su, MK, et al. (2015) Self-reported use of novel psychoactive substances in a US nationally representative survey: prevalence, correlates, and a call for new survey methods to prevent underreporting. Drug Alcohol Depend 156: 112–119. Google Scholar | Crossref | Medline | ISI | |
|
Public Opinion Research Center (2015) Oszacowanie rozpowszechnienia wybranych uzaleźnień behawioralnych oraz analiza korelacji pomiedzy wystepowaniem uzaleźnień behawioralnych a uźywaniem substancji psychoaktywnych. Ministry of Health, Warsaw. Google Scholar | |
|
Schifano, F, Leoni, M, Martinotti, G, et al. (2003) Importance of cyberspace for the assessment of the drug abuse market: preliminary results from the Psychonaut 2002 project. Cyberpsychol Behav 6: 405–410. Google Scholar | Crossref | Medline | |
|
Schifano, F, Orsolini, L, Duccio Papanti, G, et al. (2015) Novel psychoactive substances of interest for psychiatry. World Psychiatry 14: 15–26. Google Scholar | Crossref | Medline | |
|
Simons, JS, Correia, CJ, Carey, KB, et al. (1998) Validating a five-factor Marijuana Motives Measure: relations with use, problems, and alcohol motives. J Counsel Psychol 45: 265–273. Google Scholar | Crossref | ISI | |
|
Sindicich, N, Burns, L (2012) Australian Trends in Ecstasy and Related Drug Markets 2012: Findings from the Ecstasy and Related Drugs Reporting System (EDRS). Australian Drug Trends Series No.100. National Drug and Alcohol Research Centre, University of New South Wales. Available at: https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/EDRS%202012%20national%20report%20FINAL.pdf (accessed: 28 November 2017). Google Scholar | |
|
Smith, K, Flatley, J (2011) Drug Misuse Declared: Findings from the 2010/2011 British Crime Survey England and Wales. London, UK: Home Office. Google Scholar | |
|
Soussan, C, Kjellgren, A (2016) The users of novel psychoactive substances: online survey about their characteristics, attitudes and motivations. Int J Drug Policy 32: 77–84. Google Scholar | Crossref | Medline | ISI | |
|
Spaderna, M, Addy, PH, D’Souza, DC (2013) Spicing thing up: synthetic cannabinoids. Psychopharmacology 228: 525–540. Google Scholar | Crossref | Medline | ISI | |
|
Stapinski, LA, Edwards, AC, Hickman, M, et al. (2016) Drinking to cope: a latent class analysis of coping motives for alcohol use in a large cohort of adolescents. Prevent Sci 17: 584–594. Google Scholar | Crossref | Medline | |
|
Stoicea, N, Costa, A, Periel, L, et al. (2019) Current perspectives on the opioid crisis in the US healthcare system: a comprehensive literature review. Medicine (Baltimore) 98: e15425. Google Scholar | Crossref | Medline | |
|
Sutherland, R, Bruno, R, Peacock, A, et al. (2017) Motivations for new psychoactive substance use among regular psychostimulant users in Australia. Int J Drug Policy 43: 23–32. Google Scholar | Crossref | Medline | |
|
Thurn, D, Kuntsche, E, Weber, JA, et al. (2017) Development and validation of the amphetamine-type stimulants motive questionnaire in a clinical population. Front Psychiatry 8: 183. Google Scholar | Crossref | Medline | |
|
Tomkins, A, Ahmad, S, Cannon, L, et al. (2017) Prevalence of recreational drug use reported by men who have sex with men attending sexual health clinics in Manchester, UK. Int J STD AIDS 29: 350–356. Google Scholar | SAGE Journals | |
|
Vaiano, F, Pascali, JP, Bertol, E (2019) New psychoactive substances: an actual problem or an overestimated phenomenon? Forensic Sci Int 304: 109941. Google Scholar | Crossref | Medline | |
|
Van Amsterdam, JG, Nabben, T, Keiman, D, et al. (2015) Exploring the attractiveness of new psychoactive substances (NPS) among experienced drug users. J Psychoactive Drugs 47: 177–181. Google Scholar | Crossref | Medline | ISI | |
|
Van Hout, MC, Benschop, A, Bujalski, M, et al. (2018) Health and social problems associated with recent novel psychoactive substance (NPS) use amongst marginalised, nightlife and online users in six European countries. Int J Mental Health Addict 16: 480–495. Google Scholar | Crossref | Medline | |
|
Vinci, C, Spears, CA, Peltier, MR, et al. (2016) Drinking motives mediate the relationship between facets of mindfulness and problematic alcohol use. Mindfulness 7: 754–763. Google Scholar | Crossref | Medline | |
|
Winstock, AR, Mitcheson, LR, Deluca, P, et al. (2011) Mephedrone, new kid for the chop? Addiction 106: 154–161. Google Scholar | Crossref | Medline | ISI | |
|
Winstock, AR, Barratt, M, Ferris, J, et al. (2017) Global Drug Survey 2017 – Global Overview and Highlights. Available at: https://www.globaldrugsurvey.com/wp-content/themes/globaldrugsurvey/results/GDS2017_key-findings-report_final.pdf (accessed 27 November 2017) Google Scholar | |
|
Yates, A (1987) Multivariate Exploratory Data Analysis: A Perspective on Exploratory Factor Analysis. Albany, NY: State University of New York Press. Google Scholar | |
|
Zawilska, JB (2015) “Legal highs” - an emerging epidemic of novel psychoactive substances. Int Rev Neurobiol 120: 273–300. Google Scholar | Crossref | Medline | |
|
Zawilska, JB (2017) An expanding world of novel psychoactive substances: opioids. Front Psychiatry 8: 110. Google Scholar | Crossref | Medline | |
|
Zvolensky, MJ, Vujanovic, AA, Bernstein, A, et al. (2007) Marijuana use motives: a confirmatory test and evaluation among young adult marijuana users. Addict Behav 32: 3122–3130. Google Scholar | Crossref | Medline |
